Rifadin Tablets
Function and Efficacy
Not yet clear.
Ingredients
This product contains rifadin (C45H63N3O12).
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| RifampicinIngredients |
Not yet clear More |
13292-46-1 | 24 |
Appearance
This product is a sugar-coated tablet, which is orange-red after removing the sugar coating.
Indication
Suitable for the treatment of pulmonary tuberculosis, leprosy, skin tuberculosis, purulent skin diseases, etc.
Usage and Dosage
Oral. Adults: 150-200 mg per day, once in the morning on an empty stomach. Children: 3-4 mg/kg, once. The course of treatment for pulmonary tuberculosis is 1/2 to 1 year.
Adverse Reactions
Not yet clear.
Precautions
Do not use if you are allergic to this product.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
This product has cross-resistance with rifampicin, so it is not suitable for cases where rifampicin treatment is ineffective.
Storage
seal.
Packaging Specification
0.15g
Validity Period
24 months
Manufacturer
Guangzhou Maite Xinghua Drug Co., Ltd.
-
Founded in:
1984-09-07 -
Address:
Shatin, Zhongluotan Town, Baiyun District, Guangzhou -
Tax NO.:
91440101190544278L -
Registered Funds:
10.9895 million yuan -
Email: